nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Sulphaemoglobinaemia—Flutamide—prostate cancer	0.19	0.332	CcSEcCtD
Phenazopyridine—Methaemoglobinaemia—Flutamide—prostate cancer	0.0309	0.054	CcSEcCtD
Phenazopyridine—Methaemoglobinaemia—Conjugated Estrogens—prostate cancer	0.0155	0.027	CcSEcCtD
Phenazopyridine—Calculus of kidney—Bicalutamide—prostate cancer	0.0101	0.0176	CcSEcCtD
Phenazopyridine—SCN7A—prostate gland—prostate cancer	0.00964	0.147	CbGeAlD
Phenazopyridine—Nephrolithiasis—Bicalutamide—prostate cancer	0.0082	0.0143	CcSEcCtD
Phenazopyridine—SCN9A—prostate gland—prostate cancer	0.00755	0.115	CbGeAlD
Phenazopyridine—Haemolytic anaemia—Flutamide—prostate cancer	0.00731	0.0128	CcSEcCtD
Phenazopyridine—Visual disturbance—Nilutamide—prostate cancer	0.007	0.0122	CcSEcCtD
Phenazopyridine—SCN4A—prostate gland—prostate cancer	0.00674	0.103	CbGeAlD
Phenazopyridine—Visual disturbance—Estradiol valerate/Dienogest—prostate cancer	0.00658	0.0115	CcSEcCtD
Phenazopyridine—SCN3A—prostate gland—prostate cancer	0.00524	0.0798	CbGeAlD
Phenazopyridine—Jaundice—Flutamide—prostate cancer	0.00496	0.00865	CcSEcCtD
Phenazopyridine—SCN4A—renal system—prostate cancer	0.00459	0.0699	CbGeAlD
Phenazopyridine—Hepatitis—Flutamide—prostate cancer	0.00457	0.00797	CcSEcCtD
Phenazopyridine—Visual impairment—Nilutamide—prostate cancer	0.00442	0.00771	CcSEcCtD
Phenazopyridine—Visual disturbance—Ethinyl Estradiol—prostate cancer	0.00427	0.00745	CcSEcCtD
Phenazopyridine—SCN7A—testis—prostate cancer	0.00425	0.0647	CbGeAlD
Phenazopyridine—Visual impairment—Estradiol valerate/Dienogest—prostate cancer	0.00415	0.00725	CcSEcCtD
Phenazopyridine—SCN8A—testis—prostate cancer	0.00378	0.0577	CbGeAlD
Phenazopyridine—Jaundice—Bicalutamide—prostate cancer	0.0036	0.00627	CcSEcCtD
Phenazopyridine—SCN3A—renal system—prostate cancer	0.00357	0.0544	CbGeAlD
Phenazopyridine—Visual disturbance—Conjugated Estrogens—prostate cancer	0.00348	0.00607	CcSEcCtD
Phenazopyridine—SCN9A—testis—prostate cancer	0.00333	0.0507	CbGeAlD
Phenazopyridine—Visual impairment—Bicalutamide—prostate cancer	0.00319	0.00557	CcSEcCtD
Phenazopyridine—Dyspepsia—Abiraterone—prostate cancer	0.00314	0.00548	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Abiraterone—prostate cancer	0.00308	0.00537	CcSEcCtD
Phenazopyridine—SCN7A—lymph node—prostate cancer	0.00308	0.0469	CbGeAlD
Phenazopyridine—SCN4A—testis—prostate cancer	0.00297	0.0452	CbGeAlD
Phenazopyridine—Dyspepsia—Nilutamide—prostate cancer	0.00287	0.00501	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Nilutamide—prostate cancer	0.00281	0.00491	CcSEcCtD
Phenazopyridine—Visual disturbance—Estradiol—prostate cancer	0.00279	0.00486	CcSEcCtD
Phenazopyridine—SCN3A—bone marrow—prostate cancer	0.0027	0.0411	CbGeAlD
Phenazopyridine—Visual impairment—Ethinyl Estradiol—prostate cancer	0.0027	0.00471	CcSEcCtD
Phenazopyridine—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.0027	0.0047	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.00264	0.00461	CcSEcCtD
Phenazopyridine—Pruritus—Estramustine—prostate cancer	0.0026	0.00453	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Degarelix—prostate cancer	0.00251	0.00439	CcSEcCtD
Phenazopyridine—Diarrhoea—Estramustine—prostate cancer	0.00251	0.00439	CcSEcCtD
Phenazopyridine—Jaundice—Goserelin—prostate cancer	0.0025	0.00436	CcSEcCtD
Phenazopyridine—Pruritus—Estrone—prostate cancer	0.00248	0.00433	CcSEcCtD
Phenazopyridine—Diarrhoea—Abiraterone—prostate cancer	0.00244	0.00426	CcSEcCtD
Phenazopyridine—Dyspepsia—Cabazitaxel—prostate cancer	0.00241	0.00421	CcSEcCtD
Phenazopyridine—SCN9A—lymph node—prostate cancer	0.00241	0.0367	CbGeAlD
Phenazopyridine—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00237	0.00413	CcSEcCtD
Phenazopyridine—Vomiting—Estramustine—prostate cancer	0.00234	0.00408	CcSEcCtD
Phenazopyridine—Rash—Estramustine—prostate cancer	0.00232	0.00404	CcSEcCtD
Phenazopyridine—Dermatitis—Estramustine—prostate cancer	0.00231	0.00404	CcSEcCtD
Phenazopyridine—SCN3A—testis—prostate cancer	0.00231	0.0352	CbGeAlD
Phenazopyridine—Pruritus—Nilutamide—prostate cancer	0.00231	0.00402	CcSEcCtD
Phenazopyridine—Hepatitis—Goserelin—prostate cancer	0.0023	0.00402	CcSEcCtD
Phenazopyridine—Headache—Estramustine—prostate cancer	0.0023	0.00402	CcSEcCtD
Phenazopyridine—Pruritus—Flutamide—prostate cancer	0.0023	0.00401	CcSEcCtD
Phenazopyridine—Vomiting—Abiraterone—prostate cancer	0.00227	0.00396	CcSEcCtD
Phenazopyridine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00226	0.00394	CcSEcCtD
Phenazopyridine—Rash—Abiraterone—prostate cancer	0.00225	0.00393	CcSEcCtD
Phenazopyridine—Dermatitis—Abiraterone—prostate cancer	0.00225	0.00392	CcSEcCtD
Phenazopyridine—Vomiting—Estrone—prostate cancer	0.00223	0.00389	CcSEcCtD
Phenazopyridine—Diarrhoea—Nilutamide—prostate cancer	0.00223	0.00389	CcSEcCtD
Phenazopyridine—Diarrhoea—Flutamide—prostate cancer	0.00222	0.00387	CcSEcCtD
Phenazopyridine—Rash—Estrone—prostate cancer	0.00221	0.00386	CcSEcCtD
Phenazopyridine—Dermatitis—Estrone—prostate cancer	0.00221	0.00386	CcSEcCtD
Phenazopyridine—Visual impairment—Conjugated Estrogens—prostate cancer	0.0022	0.00384	CcSEcCtD
Phenazopyridine—Headache—Estrone—prostate cancer	0.0022	0.00384	CcSEcCtD
Phenazopyridine—Nausea—Estramustine—prostate cancer	0.00218	0.00381	CcSEcCtD
Phenazopyridine—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00217	0.00378	CcSEcCtD
Phenazopyridine—Hypersensitivity—Degarelix—prostate cancer	0.00215	0.00374	CcSEcCtD
Phenazopyridine—Nausea—Estrone—prostate cancer	0.00208	0.00364	CcSEcCtD
Phenazopyridine—Vomiting—Nilutamide—prostate cancer	0.00207	0.00362	CcSEcCtD
Phenazopyridine—Dyspepsia—Bicalutamide—prostate cancer	0.00207	0.00361	CcSEcCtD
Phenazopyridine—Vomiting—Flutamide—prostate cancer	0.00206	0.0036	CcSEcCtD
Phenazopyridine—Pruritus—Degarelix—prostate cancer	0.00206	0.00359	CcSEcCtD
Phenazopyridine—Rash—Nilutamide—prostate cancer	0.00206	0.00359	CcSEcCtD
Phenazopyridine—Dermatitis—Nilutamide—prostate cancer	0.00205	0.00358	CcSEcCtD
Phenazopyridine—Rash—Flutamide—prostate cancer	0.00205	0.00357	CcSEcCtD
Phenazopyridine—Dermatitis—Flutamide—prostate cancer	0.00204	0.00357	CcSEcCtD
Phenazopyridine—Headache—Nilutamide—prostate cancer	0.00204	0.00356	CcSEcCtD
Phenazopyridine—Headache—Flutamide—prostate cancer	0.00203	0.00355	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00203	0.00354	CcSEcCtD
Phenazopyridine—Hypersensitivity—Cabazitaxel—prostate cancer	0.00202	0.00353	CcSEcCtD
Phenazopyridine—Diarrhoea—Degarelix—prostate cancer	0.00199	0.00348	CcSEcCtD
Phenazopyridine—Jaundice—Estradiol—prostate cancer	0.00198	0.00346	CcSEcCtD
Phenazopyridine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00195	0.0034	CcSEcCtD
Phenazopyridine—Nausea—Nilutamide—prostate cancer	0.00194	0.00338	CcSEcCtD
Phenazopyridine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00193	0.00337	CcSEcCtD
Phenazopyridine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00193	0.00337	CcSEcCtD
Phenazopyridine—Nausea—Flutamide—prostate cancer	0.00193	0.00336	CcSEcCtD
Phenazopyridine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00192	0.00335	CcSEcCtD
Phenazopyridine—Diarrhoea—Cabazitaxel—prostate cancer	0.00188	0.00327	CcSEcCtD
Phenazopyridine—Vomiting—Degarelix—prostate cancer	0.00185	0.00323	CcSEcCtD
Phenazopyridine—Jaundice—Mitoxantrone—prostate cancer	0.00185	0.00322	CcSEcCtD
Phenazopyridine—Rash—Degarelix—prostate cancer	0.00184	0.0032	CcSEcCtD
Phenazopyridine—SCN10A—lymph node—prostate cancer	0.00184	0.028	CbGeAlD
Phenazopyridine—Dermatitis—Degarelix—prostate cancer	0.00183	0.0032	CcSEcCtD
Phenazopyridine—Hepatitis—Estradiol—prostate cancer	0.00183	0.00319	CcSEcCtD
Phenazopyridine—Headache—Degarelix—prostate cancer	0.00182	0.00318	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Capecitabine—prostate cancer	0.00182	0.00318	CcSEcCtD
Phenazopyridine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00182	0.00317	CcSEcCtD
Phenazopyridine—Visual disturbance—Docetaxel—prostate cancer	0.00179	0.00313	CcSEcCtD
Phenazopyridine—Visual impairment—Estradiol—prostate cancer	0.00176	0.00307	CcSEcCtD
Phenazopyridine—Vomiting—Cabazitaxel—prostate cancer	0.00174	0.00304	CcSEcCtD
Phenazopyridine—Hypersensitivity—Bicalutamide—prostate cancer	0.00173	0.00302	CcSEcCtD
Phenazopyridine—Nausea—Degarelix—prostate cancer	0.00173	0.00302	CcSEcCtD
Phenazopyridine—Headache—Cabazitaxel—prostate cancer	0.00172	0.003	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00172	0.003	CcSEcCtD
Phenazopyridine—Hepatitis—Mitoxantrone—prostate cancer	0.0017	0.00297	CcSEcCtD
Phenazopyridine—SCN3A—lymph node—prostate cancer	0.00167	0.0255	CbGeAlD
Phenazopyridine—Pruritus—Bicalutamide—prostate cancer	0.00166	0.0029	CcSEcCtD
Phenazopyridine—Nausea—Cabazitaxel—prostate cancer	0.00163	0.00284	CcSEcCtD
Phenazopyridine—Diarrhoea—Bicalutamide—prostate cancer	0.00161	0.00281	CcSEcCtD
Phenazopyridine—Jaundice—Etoposide—prostate cancer	0.00154	0.00268	CcSEcCtD
Phenazopyridine—Vomiting—Bicalutamide—prostate cancer	0.0015	0.00261	CcSEcCtD
Phenazopyridine—Rash—Bicalutamide—prostate cancer	0.00148	0.00259	CcSEcCtD
Phenazopyridine—Dermatitis—Bicalutamide—prostate cancer	0.00148	0.00259	CcSEcCtD
Phenazopyridine—Headache—Bicalutamide—prostate cancer	0.00147	0.00257	CcSEcCtD
Phenazopyridine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00147	0.00256	CcSEcCtD
Phenazopyridine—Dyspepsia—Goserelin—prostate cancer	0.00144	0.00251	CcSEcCtD
Phenazopyridine—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00143	0.00249	CcSEcCtD
Phenazopyridine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00141	0.00246	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.0014	0.00244	CcSEcCtD
Phenazopyridine—Nausea—Bicalutamide—prostate cancer	0.0014	0.00244	CcSEcCtD
Phenazopyridine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00136	0.00237	CcSEcCtD
Phenazopyridine—Jaundice—Docetaxel—prostate cancer	0.00128	0.00223	CcSEcCtD
Phenazopyridine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00126	0.00221	CcSEcCtD
Phenazopyridine—Rash—Ethinyl Estradiol—prostate cancer	0.00125	0.00219	CcSEcCtD
Phenazopyridine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00125	0.00219	CcSEcCtD
Phenazopyridine—Headache—Ethinyl Estradiol—prostate cancer	0.00125	0.00217	CcSEcCtD
Phenazopyridine—Jaundice—Capecitabine—prostate cancer	0.00124	0.00216	CcSEcCtD
Phenazopyridine—Hypersensitivity—Goserelin—prostate cancer	0.00121	0.0021	CcSEcCtD
Phenazopyridine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00119	0.00208	CcSEcCtD
Phenazopyridine—Nausea—Ethinyl Estradiol—prostate cancer	0.00118	0.00206	CcSEcCtD
Phenazopyridine—Hepatitis—Docetaxel—prostate cancer	0.00118	0.00205	CcSEcCtD
Phenazopyridine—Pruritus—Goserelin—prostate cancer	0.00116	0.00202	CcSEcCtD
Phenazopyridine—Pruritus—Conjugated Estrogens—prostate cancer	0.00115	0.002	CcSEcCtD
Phenazopyridine—Dyspepsia—Estradiol—prostate cancer	0.00114	0.00199	CcSEcCtD
Phenazopyridine—Hepatitis—Capecitabine—prostate cancer	0.00114	0.00199	CcSEcCtD
Phenazopyridine—Visual impairment—Docetaxel—prostate cancer	0.00113	0.00198	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Estradiol—prostate cancer	0.00112	0.00195	CcSEcCtD
Phenazopyridine—Diarrhoea—Goserelin—prostate cancer	0.00112	0.00195	CcSEcCtD
Phenazopyridine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00111	0.00194	CcSEcCtD
Phenazopyridine—Visual impairment—Capecitabine—prostate cancer	0.0011	0.00192	CcSEcCtD
Phenazopyridine—Dyspepsia—Mitoxantrone—prostate cancer	0.00106	0.00186	CcSEcCtD
Phenazopyridine—Vomiting—Goserelin—prostate cancer	0.00104	0.00182	CcSEcCtD
Phenazopyridine—Rash—Goserelin—prostate cancer	0.00103	0.0018	CcSEcCtD
Phenazopyridine—Dermatitis—Goserelin—prostate cancer	0.00103	0.0018	CcSEcCtD
Phenazopyridine—Vomiting—Conjugated Estrogens—prostate cancer	0.00103	0.0018	CcSEcCtD
Phenazopyridine—Headache—Goserelin—prostate cancer	0.00103	0.00179	CcSEcCtD
Phenazopyridine—Rash—Conjugated Estrogens—prostate cancer	0.00102	0.00178	CcSEcCtD
Phenazopyridine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00102	0.00178	CcSEcCtD
Phenazopyridine—Headache—Conjugated Estrogens—prostate cancer	0.00102	0.00177	CcSEcCtD
Phenazopyridine—Nausea—Goserelin—prostate cancer	0.000972	0.0017	CcSEcCtD
Phenazopyridine—Nausea—Conjugated Estrogens—prostate cancer	0.000963	0.00168	CcSEcCtD
Phenazopyridine—Hypersensitivity—Estradiol—prostate cancer	0.000956	0.00167	CcSEcCtD
Phenazopyridine—Pruritus—Estradiol—prostate cancer	0.000918	0.0016	CcSEcCtD
Phenazopyridine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000891	0.00155	CcSEcCtD
Phenazopyridine—Diarrhoea—Estradiol—prostate cancer	0.000888	0.00155	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000868	0.00151	CcSEcCtD
Phenazopyridine—Jaundice—Epirubicin—prostate cancer	0.000862	0.0015	CcSEcCtD
Phenazopyridine—Diarrhoea—Mitoxantrone—prostate cancer	0.000827	0.00144	CcSEcCtD
Phenazopyridine—Vomiting—Estradiol—prostate cancer	0.000825	0.00144	CcSEcCtD
Phenazopyridine—Rash—Estradiol—prostate cancer	0.000818	0.00143	CcSEcCtD
Phenazopyridine—Dermatitis—Estradiol—prostate cancer	0.000817	0.00143	CcSEcCtD
Phenazopyridine—Headache—Estradiol—prostate cancer	0.000813	0.00142	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—prostate cancer	0.000797	0.00139	CcSEcCtD
Phenazopyridine—Hepatitis—Epirubicin—prostate cancer	0.000793	0.00138	CcSEcCtD
Phenazopyridine—Nausea—Estradiol—prostate cancer	0.000771	0.00134	CcSEcCtD
Phenazopyridine—Vomiting—Mitoxantrone—prostate cancer	0.000769	0.00134	CcSEcCtD
Phenazopyridine—Visual impairment—Epirubicin—prostate cancer	0.000765	0.00133	CcSEcCtD
Phenazopyridine—Rash—Mitoxantrone—prostate cancer	0.000762	0.00133	CcSEcCtD
Phenazopyridine—Dermatitis—Mitoxantrone—prostate cancer	0.000762	0.00133	CcSEcCtD
Phenazopyridine—Headache—Mitoxantrone—prostate cancer	0.000757	0.00132	CcSEcCtD
Phenazopyridine—Hypersensitivity—Etoposide—prostate cancer	0.000741	0.00129	CcSEcCtD
Phenazopyridine—Dyspepsia—Docetaxel—prostate cancer	0.000736	0.00128	CcSEcCtD
Phenazopyridine—Hepatitis—Doxorubicin—prostate cancer	0.000734	0.00128	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000722	0.00126	CcSEcCtD
Phenazopyridine—Nausea—Mitoxantrone—prostate cancer	0.000718	0.00125	CcSEcCtD
Phenazopyridine—Dyspepsia—Capecitabine—prostate cancer	0.000712	0.00124	CcSEcCtD
Phenazopyridine—Pruritus—Etoposide—prostate cancer	0.000712	0.00124	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—prostate cancer	0.000708	0.00123	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000699	0.00122	CcSEcCtD
Phenazopyridine—Diarrhoea—Etoposide—prostate cancer	0.000688	0.0012	CcSEcCtD
Phenazopyridine—Vomiting—Etoposide—prostate cancer	0.000639	0.00112	CcSEcCtD
Phenazopyridine—Dyspepsia—Prednisone—prostate cancer	0.000634	0.00111	CcSEcCtD
Phenazopyridine—Rash—Etoposide—prostate cancer	0.000634	0.00111	CcSEcCtD
Phenazopyridine—Dermatitis—Etoposide—prostate cancer	0.000634	0.00111	CcSEcCtD
Phenazopyridine—Headache—Etoposide—prostate cancer	0.00063	0.0011	CcSEcCtD
Phenazopyridine—Hypersensitivity—Docetaxel—prostate cancer	0.000616	0.00107	CcSEcCtD
Phenazopyridine—Nausea—Etoposide—prostate cancer	0.000597	0.00104	CcSEcCtD
Phenazopyridine—Hypersensitivity—Capecitabine—prostate cancer	0.000596	0.00104	CcSEcCtD
Phenazopyridine—Pruritus—Docetaxel—prostate cancer	0.000591	0.00103	CcSEcCtD
Phenazopyridine—Pruritus—Capecitabine—prostate cancer	0.000573	0.000999	CcSEcCtD
Phenazopyridine—Diarrhoea—Docetaxel—prostate cancer	0.000572	0.000998	CcSEcCtD
Phenazopyridine—Diarrhoea—Capecitabine—prostate cancer	0.000554	0.000966	CcSEcCtD
Phenazopyridine—Vomiting—Docetaxel—prostate cancer	0.000531	0.000927	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisone—prostate cancer	0.000531	0.000927	CcSEcCtD
Phenazopyridine—Rash—Docetaxel—prostate cancer	0.000527	0.00092	CcSEcCtD
Phenazopyridine—Dermatitis—Docetaxel—prostate cancer	0.000526	0.000919	CcSEcCtD
Phenazopyridine—Headache—Docetaxel—prostate cancer	0.000524	0.000914	CcSEcCtD
Phenazopyridine—Vomiting—Capecitabine—prostate cancer	0.000514	0.000898	CcSEcCtD
Phenazopyridine—Rash—Capecitabine—prostate cancer	0.00051	0.00089	CcSEcCtD
Phenazopyridine—Pruritus—Prednisone—prostate cancer	0.00051	0.00089	CcSEcCtD
Phenazopyridine—Dermatitis—Capecitabine—prostate cancer	0.00051	0.000889	CcSEcCtD
Phenazopyridine—Headache—Capecitabine—prostate cancer	0.000507	0.000885	CcSEcCtD
Phenazopyridine—Nausea—Docetaxel—prostate cancer	0.000496	0.000866	CcSEcCtD
Phenazopyridine—Dyspepsia—Epirubicin—prostate cancer	0.000496	0.000866	CcSEcCtD
Phenazopyridine—Diarrhoea—Prednisone—prostate cancer	0.000493	0.000861	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000487	0.000849	CcSEcCtD
Phenazopyridine—Nausea—Capecitabine—prostate cancer	0.000481	0.000839	CcSEcCtD
Phenazopyridine—Dyspepsia—Doxorubicin—prostate cancer	0.000459	0.000801	CcSEcCtD
Phenazopyridine—Vomiting—Prednisone—prostate cancer	0.000458	0.0008	CcSEcCtD
Phenazopyridine—Rash—Prednisone—prostate cancer	0.000454	0.000793	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisone—prostate cancer	0.000454	0.000792	CcSEcCtD
Phenazopyridine—Headache—Prednisone—prostate cancer	0.000452	0.000788	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.00045	0.000786	CcSEcCtD
Phenazopyridine—Nausea—Prednisone—prostate cancer	0.000428	0.000747	CcSEcCtD
Phenazopyridine—Hypersensitivity—Epirubicin—prostate cancer	0.000415	0.000725	CcSEcCtD
Phenazopyridine—Pruritus—Epirubicin—prostate cancer	0.000399	0.000696	CcSEcCtD
Phenazopyridine—Diarrhoea—Epirubicin—prostate cancer	0.000386	0.000673	CcSEcCtD
Phenazopyridine—Hypersensitivity—Doxorubicin—prostate cancer	0.000384	0.000671	CcSEcCtD
Phenazopyridine—Pruritus—Doxorubicin—prostate cancer	0.000369	0.000644	CcSEcCtD
Phenazopyridine—Vomiting—Epirubicin—prostate cancer	0.000358	0.000625	CcSEcCtD
Phenazopyridine—Diarrhoea—Doxorubicin—prostate cancer	0.000357	0.000623	CcSEcCtD
Phenazopyridine—Rash—Epirubicin—prostate cancer	0.000355	0.00062	CcSEcCtD
Phenazopyridine—Dermatitis—Epirubicin—prostate cancer	0.000355	0.00062	CcSEcCtD
Phenazopyridine—Headache—Epirubicin—prostate cancer	0.000353	0.000616	CcSEcCtD
Phenazopyridine—Nausea—Epirubicin—prostate cancer	0.000335	0.000584	CcSEcCtD
Phenazopyridine—Vomiting—Doxorubicin—prostate cancer	0.000332	0.000579	CcSEcCtD
Phenazopyridine—Rash—Doxorubicin—prostate cancer	0.000329	0.000574	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—prostate cancer	0.000329	0.000573	CcSEcCtD
Phenazopyridine—Headache—Doxorubicin—prostate cancer	0.000327	0.00057	CcSEcCtD
Phenazopyridine—Nausea—Doxorubicin—prostate cancer	0.00031	0.000541	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—CTNNB1—prostate cancer	0.000158	0.000437	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—EGFR—prostate cancer	0.000156	0.000433	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—LEP—prostate cancer	0.000156	0.000432	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—LEP—prostate cancer	0.000156	0.000432	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MMP9—prostate cancer	0.000155	0.000429	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000155	0.000429	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—JAK2—prostate cancer	0.000154	0.000425	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—JAK2—prostate cancer	0.000154	0.000425	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000153	0.000425	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.000153	0.000424	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—ERBB2—prostate cancer	0.000153	0.000424	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KDR—prostate cancer	0.000153	0.000423	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KDR—prostate cancer	0.000153	0.000423	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—JAK2—prostate cancer	0.000153	0.000423	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000152	0.00042	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—LEP—prostate cancer	0.00015	0.000417	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—LEP—prostate cancer	0.00015	0.000417	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ERBB2—prostate cancer	0.000148	0.000409	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—ERBB2—prostate cancer	0.000148	0.000409	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—KRAS—prostate cancer	0.000148	0.000409	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KDR—prostate cancer	0.000147	0.000408	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KDR—prostate cancer	0.000147	0.000408	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ERBB2—prostate cancer	0.000147	0.000407	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000147	0.000407	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—GSK3B—prostate cancer	0.000147	0.000407	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—EP300—prostate cancer	0.000147	0.000406	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000146	0.000404	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KDR—prostate cancer	0.000145	0.000402	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—INS—prostate cancer	0.000145	0.000402	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000144	0.000397	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP9—prostate cancer	0.000143	0.000396	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—EGFR—prostate cancer	0.000143	0.000396	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—prostate cancer	0.000143	0.000395	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CREBBP—prostate cancer	0.000142	0.000393	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VAV3—prostate cancer	0.000142	0.000393	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CTNNB1—prostate cancer	0.000141	0.00039	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—GSK3B—prostate cancer	0.000141	0.000389	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—prostate cancer	0.000139	0.000385	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—INS—prostate cancer	0.000139	0.000384	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—prostate cancer	0.000138	0.000382	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—STAT3—prostate cancer	0.000138	0.000381	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MMP9—prostate cancer	0.000137	0.000379	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CREBBP—prostate cancer	0.000136	0.000376	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP2—prostate cancer	0.000136	0.000376	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAP2K1—prostate cancer	0.000136	0.000375	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.000135	0.000374	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—GSK3B—prostate cancer	0.000135	0.000374	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KRAS—prostate cancer	0.000135	0.000374	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—prostate cancer	0.000135	0.000373	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—INS—prostate cancer	0.000133	0.000369	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—INS—prostate cancer	0.000133	0.000369	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—prostate cancer	0.000132	0.000365	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—prostate cancer	0.000131	0.000364	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—prostate cancer	0.000131	0.000364	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EP300—prostate cancer	0.000131	0.000362	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.000131	0.000361	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CREBBP—prostate cancer	0.000131	0.000361	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—GSK3B—prostate cancer	0.00013	0.000361	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—GSK3B—prostate cancer	0.00013	0.000361	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP2—prostate cancer	0.00013	0.00036	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAP2K1—prostate cancer	0.00013	0.000359	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—FGF2—prostate cancer	0.000129	0.000357	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CTNNB1—prostate cancer	0.000129	0.000356	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—INS—prostate cancer	0.000129	0.000356	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—INS—prostate cancer	0.000129	0.000356	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—prostate cancer	0.000128	0.000356	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—GSK3B—prostate cancer	0.000128	0.000355	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—prostate cancer	0.000128	0.000353	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—prostate cancer	0.000127	0.000352	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—prostate cancer	0.000127	0.000351	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP9—prostate cancer	0.000127	0.000351	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—prostate cancer	0.000126	0.000349	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LPL—prostate cancer	0.000126	0.000349	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—prostate cancer	0.000126	0.000349	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CREBBP—prostate cancer	0.000126	0.000349	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CREBBP—prostate cancer	0.000126	0.000349	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—EGFR—prostate cancer	0.000125	0.000346	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.000125	0.000345	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP2—prostate cancer	0.000125	0.000345	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAP2K1—prostate cancer	0.000125	0.000345	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.000125	0.000345	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—prostate cancer	0.000124	0.000343	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—JAK2—prostate cancer	0.000124	0.000342	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—FGF2—prostate cancer	0.000123	0.000342	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—prostate cancer	0.000123	0.00034	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—STAT3—prostate cancer	0.000123	0.00034	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.000122	0.000337	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—prostate cancer	0.000121	0.000335	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—prostate cancer	0.000121	0.000335	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP2—prostate cancer	0.00012	0.000333	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP2—prostate cancer	0.00012	0.000333	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAP2K1—prostate cancer	0.00012	0.000333	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAP2K1—prostate cancer	0.00012	0.000333	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—prostate cancer	0.00012	0.000332	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EP300—prostate cancer	0.00012	0.000331	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ERBB2—prostate cancer	0.000119	0.000329	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP2—prostate cancer	0.000119	0.000328	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—FGF2—prostate cancer	0.000119	0.000328	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.000119	0.000328	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.000118	0.000328	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—JAK2—prostate cancer	0.000118	0.000327	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—prostate cancer	0.000118	0.000327	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.000118	0.000327	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—prostate cancer	0.000118	0.000327	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SRC—prostate cancer	0.000117	0.000323	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—prostate cancer	0.000117	0.000323	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—prostate cancer	0.000116	0.000322	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—EGFR—prostate cancer	0.000116	0.00032	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—FGF2—prostate cancer	0.000114	0.000316	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—FGF2—prostate cancer	0.000114	0.000316	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ERBB2—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—JAK2—prostate cancer	0.000114	0.000315	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—prostate cancer	0.000113	0.000314	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—STAT3—prostate cancer	0.000112	0.000311	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EGFR—prostate cancer	0.000112	0.000309	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARA—prostate cancer	0.000111	0.000309	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—EGFR—prostate cancer	0.000111	0.000306	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—prostate cancer	0.00011	0.000304	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—JAK2—prostate cancer	0.00011	0.000303	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—JAK2—prostate cancer	0.00011	0.000303	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000109	0.000303	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ERBB2—prostate cancer	0.000109	0.000303	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—prostate cancer	0.000109	0.000302	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—JAK2—prostate cancer	0.000108	0.000299	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000106	0.000294	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—EGFR—prostate cancer	0.000106	0.000294	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LEP—prostate cancer	0.000106	0.000293	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ERBB2—prostate cancer	0.000105	0.000292	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ERBB2—prostate cancer	0.000105	0.000292	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—prostate cancer	0.000105	0.000292	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—prostate cancer	0.000104	0.000289	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CTNNB1—prostate cancer	0.000104	0.000288	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—prostate cancer	0.000104	0.000288	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000104	0.000288	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KDR—prostate cancer	0.000104	0.000287	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—EGFR—prostate cancer	0.000102	0.000284	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—EGFR—prostate cancer	0.000102	0.000284	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—prostate cancer	0.000102	0.000283	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EGFR—prostate cancer	0.000102	0.000282	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—prostate cancer	0.0001	0.000278	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—prostate cancer	0.0001	0.000278	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CTNNB1—prostate cancer	9.96e-05	0.000276	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	9.93e-05	0.000275	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—prostate cancer	9.76e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EP300—prostate cancer	9.68e-05	0.000268	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—prostate cancer	9.68e-05	0.000268	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—prostate cancer	9.68e-05	0.000268	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—prostate cancer	9.63e-05	0.000267	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—prostate cancer	9.61e-05	0.000266	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CTNNB1—prostate cancer	9.57e-05	0.000265	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	9.57e-05	0.000265	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SRC—prostate cancer	9.41e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—prostate cancer	9.38e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—prostate cancer	9.38e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EP300—prostate cancer	9.26e-05	0.000256	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CTNNB1—prostate cancer	9.23e-05	0.000255	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CTNNB1—prostate cancer	9.23e-05	0.000255	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—prostate cancer	9.17e-05	0.000254	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GSK3B—prostate cancer	9.16e-05	0.000254	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—STAT3—prostate cancer	9.08e-05	0.000251	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—prostate cancer	9.04e-05	0.00025	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—prostate cancer	9.04e-05	0.00025	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—INS—prostate cancer	9.04e-05	0.00025	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—prostate cancer	9e-05	0.000249	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP9—prostate cancer	8.91e-05	0.000247	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EP300—prostate cancer	8.89e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EP300—prostate cancer	8.89e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—prostate cancer	8.88e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—prostate cancer	8.87e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CREBBP—prostate cancer	8.85e-05	0.000245	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—prostate cancer	8.77e-05	0.000243	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—STAT3—prostate cancer	8.68e-05	0.00024	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—prostate cancer	8.65e-05	0.000239	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—prostate cancer	8.65e-05	0.000239	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EP300—prostate cancer	8.58e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EP300—prostate cancer	8.58e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—prostate cancer	8.57e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—prostate cancer	8.5e-05	0.000235	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP2—prostate cancer	8.46e-05	0.000234	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	8.45e-05	0.000234	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—prostate cancer	8.42e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—prostate cancer	8.42e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—prostate cancer	8.41e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—STAT3—prostate cancer	8.34e-05	0.000231	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—STAT3—prostate cancer	8.34e-05	0.000231	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—prostate cancer	8.34e-05	0.000231	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—prostate cancer	8.34e-05	0.000231	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EGFR—prostate cancer	8.25e-05	0.000228	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—prostate cancer	8.22e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—prostate cancer	8.16e-05	0.000226	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—prostate cancer	8.16e-05	0.000226	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—prostate cancer	8.12e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—prostate cancer	8.12e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—prostate cancer	8.05e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—STAT3—prostate cancer	8.04e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—STAT3—prostate cancer	8.04e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FGF2—prostate cancer	8.04e-05	0.000222	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—prostate cancer	8e-05	0.000221	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—prostate cancer	7.91e-05	0.000219	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EGFR—prostate cancer	7.89e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—prostate cancer	7.87e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—prostate cancer	7.87e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—prostate cancer	7.84e-05	0.000217	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—prostate cancer	7.79e-05	0.000216	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—prostate cancer	7.73e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—prostate cancer	7.73e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—JAK2—prostate cancer	7.7e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EGFR—prostate cancer	7.58e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EGFR—prostate cancer	7.58e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—prostate cancer	7.45e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—prostate cancer	7.45e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—prostate cancer	7.45e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ERBB2—prostate cancer	7.41e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EGFR—prostate cancer	7.31e-05	0.000202	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EGFR—prostate cancer	7.31e-05	0.000202	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—prostate cancer	7.23e-05	0.0002	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—EGFR—prostate cancer	7.2e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—prostate cancer	7.16e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—prostate cancer	7.16e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—prostate cancer	6.9e-05	0.000191	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—prostate cancer	6.9e-05	0.000191	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—prostate cancer	6.8e-05	0.000188	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	6.49e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—prostate cancer	6.36e-05	0.000176	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—prostate cancer	6.34e-05	0.000175	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—prostate cancer	6.06e-05	0.000168	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EP300—prostate cancer	6.03e-05	0.000167	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—prostate cancer	5.86e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—prostate cancer	5.85e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—prostate cancer	5.83e-05	0.000161	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—prostate cancer	5.83e-05	0.000161	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—prostate cancer	5.71e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—STAT3—prostate cancer	5.65e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—prostate cancer	5.62e-05	0.000155	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—prostate cancer	5.62e-05	0.000155	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—prostate cancer	5.59e-05	0.000155	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—prostate cancer	5.53e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—prostate cancer	5.37e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—prostate cancer	5.37e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—prostate cancer	5.24e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—prostate cancer	5.18e-05	0.000143	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—prostate cancer	5.18e-05	0.000143	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EGFR—prostate cancer	5.14e-05	0.000142	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—prostate cancer	4.85e-05	0.000134	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—prostate cancer	3.95e-05	0.000109	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—prostate cancer	3.64e-05	0.000101	CbGpPWpGaD
